Vasishta Harekal

| Software Engineering | Education | Karnataka | Global Mentorship Network

[Mohandas Pai @TVMohandasPai]

Shocking!

[Mahesh Jethmalani @JethmalaniM]

400 + history-sheeters
2000 + people with criminal background.
Who brought them to the protest at Jantar Mantar?
Where did the funding come from?
Who are the foreign funders?

Arnab at @republic, as usual, asks the right questions and raises more questions!

[Mahesh Jethmalani @JethmalaniM]

It’s all about the Foreign Contribution (Regulation) Act (FCRA) bill. Too many foreign countries and their nefarious designs in India will come to a screeching halt.

[Abhijit Majumder @abhijitmajumder]

CREEPY COCKROACHES.
This is how so-called ‘students’ at CJP protests touched and heckled a woman journalist.
The situation could have descended into Pakistani men’s favourite game, taharrush gamea.
Women and girls are not safe around this violent mob.

[Ananth Rupanagudi @AnanthOnTrack]

An Indian scientist at Harvard discovered ATP (Adenosine Triphosphate). Then he helped create the first chemotherapy drug and the first tetracycline antibiotic. Harvard still refused him tenure. A bowling alley would not let him bowl. He died at 53, without an obituary.

His medicines save tens of millions of lives every year. Most American doctors who prescribe them have no idea what his name was. His name was Yellapragada Subbarow (Subba Rao).

He was born in 1895 in Bhimavaram, India. His father was a Sanskrit scholar who died from tropical sprue. Tropical sprue is an acquired malabsorptive disorder found in tropical regions, characterized by chronic diarrhea, weight loss, and severe nutritional deficiencies. It is most commonly associated with deficiencies in vitamin B12 and folic acid, resulting in anemia, fatigue, and glossitis. The same disease killed two of his brothers. As a child, Subbarow watched them fade away and decided he would spend his life fighting disease.

He failed his school exams twice. Passed on the third attempt. His future father-in-law paid for his medical school books. Subbarow married his daughter and repaid the debt. In October 1922, he arrived in Boston with borrowed money and broken English. He was 27. He entered Harvard Medical School and joined the biochemistry PhD program.

He began working under a senior researcher named Cyrus Fiske. Long hours. Little pay. But he was at Harvard, and he did not care. In 1925, they developed the Fiske-SubbaRow assay, a method for measuring phosphorus in body fluids. It is still used today in kidney failure testing, vitamin D testing, and prostate cancer work. It became one of the most cited methods in biochemistry history.

Then they found something even bigger in 1926 - ATP - Adenosine triphosphate. The energy molecule that powers every cell in every living thing on Earth. That discovery changed biochemistry. It also proved that the 1922 Nobel laureate had been wrong about how muscles worked. Muscles did not run on glycogen. They ran on ATP.

Subbarow earned his PhD in 1930. He stayed at Harvard for another decade. Paper after paper. Discovery after discovery. And every year, Harvard refused to promote him. The biochemistry department had never given tenure to a foreigner. They were not going to begin with an Indian.

His colleagues took him fishing. Played tennis with him. Came to dinner at his home. Then voted against him year after year. Outside the laboratory, he met the same wall. He bought an airplane and learned to fly because he loved flying. Once, he tried to go bowling. The local alley refused him entry. The sign said it was “open only to the Caucasian race.”

Then Fiske turned against him. The senior researcher began blocking Subbarow’s discoveries out of jealousy. Some of Subbarow’s work had to be rediscovered years later by other scientists because Fiske kept his findings hidden.

May 1940. Harvard denied him tenure for the last time. After 17 years of groundbreaking work, he walked away. Lederle Laboratories in New York hired him as Associate Director of Research. By the end of the year, he was Director. In the next eight years, he changed medicine. He developed diethylcarbamazine, an oral medicine that killed the tropical worms crippling American soldiers in the Pacific. The World Health Organization still uses it.

He isolated folic acid from liver and worked out how to produce it on a large scale. Today, folic acid in pregnancy prevents birth defects in tens of millions of pregnancies every year. The same family of diseases that killed his father and brothers became preventable because of him.

Then Dr. Sidney Farber called from Boston with an idea: maybe a drug that blocked folic acid in cancer cells could kill childhood leukemia. Subbarow’s team created the drug. They called it Aminopterin. In December 1947, Farber gave it to an eight-year-old boy dying from leukemia. Within weeks, the cancer cells began to disappear.

It was the first chemotherapy drug in history. The first time anyone had put cancer into remission using a pill. Subbarow’s team later refined it into Amethopterin, now known as methotrexate. It became a gold standard treatment for leukemia, lymphoma, breast cancer, and lung cancer. Then rheumatoid arthritis, psoriasis, and Crohn’s disease. The World Health Organization lists it as an essential medicine. Tens of millions of people use it every year.

In 1948, his lab produced Aureomycin. The first tetracycline antibiotic - a broad-spectrum one that killed typhus, cholera, pneumonia, and many bacteria that penicillin could not touch. It opened the door to the whole tetracycline family: doxycycline, minocycline, and drugs still used today against plague, malaria, anthrax, and drug-resistant infections.

He was 53 years old. He had created medicines that would save tens of millions of lives. August 8, 1948. Yellapragada Subbarow suffered a heart attack at his home in New York and died. No American newspaper gave him a front-page obituary. No university held a memorial. The Nobel Committee never honoured him. His own colleague George Hitchings later won a 1988 Nobel Prize for work built directly on Subbarow’s foundation. Subbarow was not even nominated.

In 1950, Argosy magazine published a feature about him titled “Miracle Man of the Miracle Drugs.” It began with a line that still hits hard. “You’ve probably never heard of Dr. Yellapragada Subbarow. Yet because he lived, you may be alive and are well today. Because he lived, you may live longer.”

Most Americans had not heard of him in 1950. Most still have not. Harvard has never officially honoured him. American medical schools mostly do not teach his name. The Nobel Committee that honoured Hitchings for work built on his foundation never corrected the record. Every methotrexate prescription written today remains silent about the man behind it.

India remembers. The government issued a postage stamp for his 100th birthday. His childhood home became a museum. Indian medical schools teach his name. But the country that denied him tenure, refused to let him bowl, and allowed him to die unknown - the same country that uses his drugs every day - still mostly does not know him.

Here is the truth. If someone you know has ever taken methotrexate for cancer or an autoimmune disease. If someone you love has taken folic acid during pregnancy. If you have ever been prescribed doxycycline for an infection. That was him. Yellapragada Subbarow. Born 1895. Died 1948. Saved tens of millions of lives, while a country he loved barely knows what it owes him.

Please remember his name and let your near and dear know about this little-known scientific legend born on this soil but never got the true recognition that he deserved. A story you need to know. A story all of us need to know. #Medicine #Unknownlegends @centerofright @KiranKS

[Sam Peak 🇺🇸💡 @SpeakSamuel]

This H-1B worker has lived in the US for nearly 20 years and built a family here. His mom was dying in India. To visit her, he would need to wait months to book a consular appointment--with the soonest one available likely being scheduled one year out.

He made the difficult choice of not visiting his dying mom because leaving without an appointment would mean separation from his children, job, and his other obligations.

Much of the commentary around immigration focuses on how such bureaucratic burdens undermine immigrants’ ability to contribute and innovate. But we must remember that this red tape also prevents these people from being fully engaged with their own lives and meaningfully present in the lives of others. This matters too, and these seemingly non-economic problems will eventually translate into economic costs.

If America is no longer a place where people feel empowered to be the best versions of themselves as they celebrate, struggle, and grieve, it ceases not just being the land of opportunity, but also the land of dignity and purpose.
https://t.co/k17YL25nc5

[anand mahindra @anandmahindra]

The quality of urban life is ultimately shaped by the collective participation of its community.

No amount of physical infrastructure can substitute for thst…

(Video courtesy @Nagaland_India )

[Vasishta Harekal @vasishta_hd]

Looks like my Twitter Account has been hacked & lot of my recent tweets are not something I tweeted.

[Vasishta Harekal @vasishta_hd]

@nuhbeg @ZssBecker Wow really interesting be bright in future ..i believe that it will

[Vasishta Harekal @vasishta_hd]

@ZssBecker Big things coming Exciting times ahead. Impressive growth potential!

[Vasishta Harekal @vasishta_hd]

@Intjective @Injective_ @3rdWiz4rd @solana @phantom Let's make it successful

[Vasishta Harekal @vasishta_hd]

@nuhbeg @ZssBecker You made a good decision to move to Polygon and need help spreading the news. Clarify benefits.